Company · CIK 0001109196 · SIC 2834 — Pharmaceutical Preparations
MABVAX THERAPEUTICS HOLDINGS, INC. · MBVX
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 3, 2018 MForm 4 → | Apr 3, 9:16 pm EDT | Thomas C VarvaroDirector | 513 | — | — | 23,063 | — | plan? |
| Apr 2, 2018 MForm 4/A → | Apr 4, 4:15 pm EDT | Kenneth M CohenDirector | 513 | — | — | 24,552 | — | plan? |
| Apr 2, 2018 MForm 4/A → | Apr 4, 6:13 am EDT | Paul V MaierDirector | 513 | — | — | 23,063 | — | plan? |
| Apr 2, 2018 MForm 4 → | Apr 3, 6:26 pm EDT | Paul V MaierDirector | 513 | — | — | 23,462 | — | plan? amended |
| Apr 2, 2018 MForm 4 → | Apr 3, 6:26 pm EDT | Kenneth M CohenDirector | 513 | — | — | 26,808 | — | plan? amended |
| Apr 2, 2018 FMForm 4 → | Apr 3, 6:25 pm EDT | Paul W MaffuidEXEC. VP, R AND D | 6,750 | — | — | 99,877 | — | plan? |
| Apr 2, 2018 FMForm 4 → | Apr 3, 6:24 pm EDT | Gregory P HansonCHIEF FINANCIAL OFFICER, SECR | 9,449 | — | — | 114,307 | — | plan? |
| Apr 2, 2018 FMForm 4 → | Apr 3, 6:23 pm EDT | John David HansenPRESIDENT AND CEO, Director | 18,250 | — | — | 190,827 | — | plan? |
| Jan 23, 2018 SForm 4 → | Jan 24, 7:13 pm EST | Jeffrey F EisenbergDirector | 35,442 | $0.8548 | $30,295 | 64,558 | −35.4% | plan? |
| Jan 23, 2018 SForm 4 → | Jan 24, 7:10 pm EST | Thomas C VarvaroDirector | 35,441 | $0.8548 | $30,294 | 67,645 | −34.4% | plan? |
| Jan 23, 2018 SForm 4 → | Jan 24, 7:09 pm EST | Paul V MaierDirector | 35,448 | $0.8548 | $30,300 | 68,314 | −34.2% | plan? |
| Jan 23, 2018 SForm 4 → | Jan 24, 7:06 pm EST | Kenneth M CohenDirector | 35,440 | $0.8548 | $30,293 | 78,355 | −31.1% | plan? |
| Jan 16, 2018 SForm 4 → | Jan 18, 8:00 pm EST | Paul W MaffuidEXECUTIVE VICE PRESIDENT | 38,054 | $0.92 | $35,010 | 283,703 | −11.8% | plan? |
| Jan 16, 2018 SForm 4 → | Jan 18, 8:00 pm EST | John David HansenPRESIDENT AND CEO, Director | 59,263 | $0.92 | $54,522 | 536,730 | −9.94% | plan? |
| Jan 16, 2018 SForm 4 → | Jan 18, 8:00 pm EST | Paul F ResnickVICE PRESIDENT, CBO | 3,071 | $0.92 | $2,825 | 18,333 | −14.3% | plan? |
| Jan 16, 2018 SForm 4 → | Jan 18, 8:00 pm EST | Gregory P HansonCHIEF FINANCIAL OFFICER, SECR | 41,873 | $0.92 | $38,523 | 320,013 | −11.6% | plan? |
| Jan 10, 2018 SForm 4 → | Jan 16, 6:00 am EST | Gregory P HansonCHIEF FINANCIAL OFFICER, SECR | 116,479 | $0.9666 | $112,594 | 361,886 | −24.3% | plan? late |
| Jan 10, 2018 SForm 4 → | Jan 16, 6:00 am EST | Paul F ResnickVICE PRESIDENT, CBO | 8,540 | $0.9666 | $8,255 | 21,404 | −28.5% | plan? late |
| Jan 10, 2018 SForm 4 → | Jan 16, 6:00 am EST | Paul W MaffuidEXECUTIVE VICE PRESIDENT | 105,851 | $0.9666 | $102,320 | 321,757 | −24.8% | plan? late |
| Jan 10, 2018 SForm 4 → | Jan 16, 6:00 am EST | Philip O. LivingstonCHIEF SCIENCE OFFICER, Director | 37,027 | $0.9666 | $35,792 | 256,554 | −12.6% | plan? late |
| Jan 10, 2018 SForm 4 → | Jan 16, 6:00 am EST | John David HansenPRESIDENT AND CEO, Director | 192,690 | $0.9666 | $186,263 | 595,993 | −24.4% | plan? late |
| Jan 8, 2018 MForm 4 → | Jan 16, 6:00 am EST | Gregory P HansonCHIEF FINANCIAL OFFICER, SECR | 449,159 | — | — | 478,365 | — | plan? late |
| Jan 8, 2018 MForm 4 → | Jan 16, 6:00 am EST | Paul F ResnickVICE PRESIDENT, CBO | 29,944 | — | — | 29,944 | — | plan? late |
| Jan 8, 2018 MForm 4 → | Jan 16, 6:00 am EST | Paul W MaffuidEXECUTIVE VICE PRESIDENT | 406,382 | — | — | 427,608 | — | plan? late |
| Jan 8, 2018 MForm 4 → | Jan 16, 6:00 am EST | Philip O. LivingstonCHIEF SCIENCE OFFICER, Director | 100,000 | — | — | 293,581 | — | plan? late |
| Jan 8, 2018 MForm 4 → | Jan 16, 6:00 am EST | John David HansenPRESIDENT AND CEO, Director | 727,210 | — | — | 788,683 | — | plan? late |
| Jan 8, 2018 MForm 4 → | Jan 12, 5:26 pm EST | Thomas C VarvaroDirector | 100,000 | — | — | 100,000 | — | plan? late |
| Jan 8, 2018 MForm 4 → | Jan 12, 5:25 pm EST | Kenneth M CohenDirector | 100,000 | — | — | 100,000 | — | plan? late |
| Jan 8, 2018 MForm 4 → | Jan 12, 5:23 pm EST | Jeffrey F EisenbergDirector | 100,000 | — | — | 100,000 | — | plan? late |
| Jan 8, 2018 MForm 4 → | Jan 12, 5:22 pm EST | Paul V MaierDirector | 100,000 | — | — | 100,000 | — | plan? late |
| May 19, 2017 PForm 4 → | Aug 2, 6:02 am EDT | John David HansenPRESIDENT AND CEO, Director | 4,842 | — | — | 70,601 | — | plan? late |
| May 19, 2017 PForm 4 → | Aug 2, 6:02 am EDT | John David HansenPRESIDENT AND CEO, Director | 4,286 | $1.75 | $7,501 | 65,759 | +6.97% | plan? late |
| May 19, 2017 PForm 4 → | Aug 2, 6:01 am EDT | Gregory P HansonCHIEF FINANCIAL OFFICER, SECR | 4,842 | — | — | 38,334 | — | plan? late |
| May 19, 2017 PForm 4 → | Aug 2, 6:01 am EDT | Gregory P HansonCHIEF FINANCIAL OFFICER, SECR | 4,286 | $1.75 | $7,501 | 33,492 | +14.7% | plan? late |
| May 19, 2017 PForm 4 → | Aug 2, 6:00 am EDT | Paul W MaffuidEXECUTIVE VICE PRESIDENT | 3,228 | — | — | 27,311 | — | plan? late |
| May 19, 2017 PForm 4 → | Aug 2, 6:00 am EDT | Paul W MaffuidEXECUTIVE VICE PRESIDENT | 2,857 | $1.75 | $5,000 | 24,083 | +13.5% | plan? late |
| Apr 12, 2017 SForm 4 → | Apr 14, 5:24 pm EDT | Paul W MaffuidEXECUTIVE VICE PRESIDENT | 1,369 | $2.00 | $2,738 | 21,226 | −6.06% | plan? |
| Apr 12, 2017 SForm 4 → | Apr 14, 5:22 pm EDT | Gregory P HansonCHIEF FINANCIAL OFFICER, SECR | 3,885 | $2.00 | $7,770 | 29,206 | −11.7% | plan? |
| Apr 12, 2017 SForm 4 → | Apr 14, 5:21 pm EDT | John David HansenPRESIDENT AND CEO, Director | 10,216 | $2.00 | $20,433 | 61,473 | −14.3% | plan? |
| Apr 7, 2017 SForm 4 → | Apr 11, 6:32 pm EDT | Paul W MaffuidEXECUTIVE VICE PRESIDENT | 1,050 | $2.00 | $2,102 | 22,595 | −4.44% | plan? |
| Apr 7, 2017 SForm 4 → | Apr 11, 6:31 pm EDT | Gregory P HansonCHIEF FINANCIAL OFFICER, SECR | 1,050 | $2.00 | $2,102 | 33,091 | −3.08% | plan? |
| Apr 7, 2017 SForm 4 → | Apr 11, 6:30 pm EDT | John David HansenPRESIDENT AND CEO, Director | 1,476 | $2.00 | $2,955 | 71,689 | −2.02% | plan? |
| Apr 4, 2017 SForm 4 → | Apr 6, 6:58 pm EDT | Paul W MaffuidEXECUTIVE VICE PRESIDENT | 3,667 | $2.18 | $7,984 | 23,645 | −13.4% | plan? |
| Apr 4, 2017 SForm 4 → | Apr 6, 6:57 pm EDT | Gregory P HansonCHIEF FINANCIAL OFFICER, SECR | 3,667 | $2.18 | $7,984 | 34,141 | −9.70% | plan? |
| Apr 4, 2017 SForm 4 → | Apr 6, 6:57 pm EDT | John David HansenPRESIDENT AND CEO, Director | 5,051 | $2.17 | $10,969 | 73,165 | −6.46% | plan? |
| Apr 2, 2017 MForm 4 → | Apr 4, 9:50 pm EDT | Jeffrey V. RavetchDirector | 1,543 | — | — | 3,086 | — | plan? |
| Apr 2, 2017 MForm 4 → | Apr 4, 7:25 pm EDT | Paul W MaffuidEXECUTIVE VICE PRESIDENT | 15,045 | — | — | 27,312 | — | plan? |
| Apr 2, 2017 MForm 4 → | Apr 4, 7:24 pm EDT | Gregory P HansonCHIEF FINANCIAL OFFICER, SECR | 21,064 | — | — | 37,808 | — | plan? |
| Apr 2, 2017 MForm 4 → | Apr 4, 7:23 pm EDT | John David HansenPRESIDENT AND CEO, Director | 40,687 | — | — | 78,216 | — | plan? |
| Apr 2, 2017 MForm 4 → | Apr 4, 7:23 pm EDT | Robert HoffmanDirector | 1,543 | — | — | 4,438 | — | plan? |
| Apr 2, 2017 MForm 4 → | Apr 4, 7:22 pm EDT | Kenneth M CohenDirector | 1,543 | — | — | 7,557 | — | plan? |
| Apr 2, 2017 MForm 4 → | Apr 4, 7:22 pm EDT | Paul V MaierDirector | 1,543 | — | — | 3,762 | — | plan? |
| Apr 2, 2017 MForm 4 → | Apr 4, 7:21 pm EDT | Thomas C VarvaroDirector | 1,543 | — | — | 3,086 | — | plan? |
| Aug 17, 2016 PForm 4 → | Aug 19, 4:38 pm EDT | John David HansenPRESIDENT AND CEO, Director | 3,119 | — | — | 37,529 | — | plan? |
| Aug 17, 2016 PForm 4 → | Aug 19, 4:36 pm EDT | Gregory P HansonCHIEF FINANCIAL OFFICER, SECR | 3,119 | — | — | 16,744 | — | plan? |
| Aug 17, 2016 PForm 4 → | Aug 19, 4:35 pm EDT | Paul W MaffuidEXECUTIVE VICE PRESIDENT | 2,079 | — | — | 12,267 | — | plan? |
| Aug 17, 2016 PForm 4 → | Aug 19, 4:34 pm EDT | Kenneth M CohenDirector | 3,119 | — | — | 6,014 | — | plan? |
| Apr 4, 2016 FMForm 4 → | Apr 5, 6:01 pm EDT | Wolfgang W. ScholzVP OF ANTIBODY DISCOVERY | 139,904 | — | — | 113,288 | — | plan? |
| Apr 4, 2016 MForm 4 → | Apr 5, 6:00 pm EDT | Robert HoffmanDirector | 11,417 | — | — | 21,417 | — | plan? |
| Apr 4, 2016 MForm 4 → | Apr 5, 5:59 pm EDT | Thomas C VarvaroDirector | 11,417 | — | — | 11,417 | — | plan? |
| Apr 4, 2016 MForm 4 → | Apr 5, 5:58 pm EDT | Jeffrey V. RavetchDirector | 11,417 | — | — | 11,417 | — | plan? |
| Apr 4, 2016 MForm 4 → | Apr 5, 5:57 pm EDT | Kenneth M CohenDirector | 11,417 | — | — | 11,417 | — | plan? |
| Apr 4, 2016 MForm 4 → | Apr 5, 5:56 pm EDT | Paul V MaierDirector | 11,417 | — | — | 16,417 | — | plan? |
| Apr 4, 2016 FMForm 4 → | Apr 5, 5:56 pm EDT | John David HansenPRESIDENT AND CEO, Director | 414,232 | — | — | 254,634 | — | plan? |
| Apr 4, 2016 FMForm 4 → | Apr 5, 5:55 pm EDT | Paul W MaffuidEXECUTIVE VICE PRESIDENT | 152,278 | — | — | 75,390 | — | plan? |
| Apr 4, 2016 FMForm 4 → | Apr 5, 5:54 pm EDT | Gregory P HansonCHIEF FINANCIAL OFFICER, SECR | 213,911 | — | — | 100,823 | — | plan? |
| Mar 24, 2016 SForm 4/A → | Mar 25, 2:54 pm EDT | Jeffrey V. RavetchDirector | 131,500 | $0.60 | $78,900 | 0 | −100% | plan? |
| Mar 24, 2016 SForm 4 → | Mar 24, 6:26 pm EDT | Jeffrey V. RavetchDirector | 131,500 | $0.60 | $78,900 | 0 | −100% | plan? amended |
| May 29, 2015 PForm 4 → | Jun 2, 3:46 pm EDT | Paul V MaierDirector | 5,000 | $2.30 | $11,500 | 5,000 | — | plan? |
| May 22, 2015 PForm 4 → | May 26, 1:18 pm EDT | Kenneth M CohenDirector | 3,500 | $2.30 | $8,050 | 10,000 | +53.8% | plan? |
| Apr 4, 2015 AForm 4 → | Apr 7, 8:39 pm EDT | Michael M WickDirector | 20,000 | — | — | 33,551 | — | plan? |
| Apr 4, 2015 AForm 4 → | Apr 7, 8:38 pm EDT | Jeffrey V. RavetchDirector | 131,500 | — | — | 131,500 | — | plan? |
| Apr 4, 2015 AForm 4 → | Apr 7, 8:36 pm EDT | Philip O. LivingstonChief Science Officer, Director | 1,000,000 | — | — | 1,307,396 | — | plan? |
| Dec 16, 2014 PForm 5 → | Jan 8, 2015, 12:44 pm EST | Paul W MaffuidVice President | 5,000 | $2.85 | $14,250 | 5,000 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 29, 2016 AForm 4 → | Jul 28, 5:49 pm EDT | Thomas C VarvaroDirector | 35,000 | $0.55 | $19,250 | 35,000 | — | late |
| Jun 29, 2016 AForm 4 → | Jul 28, 5:48 pm EDT | Jeffrey V. RavetchDirector | 35,000 | $0.55 | $19,250 | 35,000 | — | late |
| Jun 29, 2016 AForm 4 → | Jul 28, 5:47 pm EDT | Robert HoffmanDirector | 35,000 | $0.55 | $19,250 | 35,000 | — | late |
| Jun 29, 2016 AForm 4 → | Jul 28, 5:46 pm EDT | Kenneth M CohenDirector | 35,000 | $0.55 | $19,250 | 35,000 | — | late |
| Jun 29, 2016 AForm 4 → | Jul 28, 5:44 pm EDT | Paul V MaierDirector | 35,000 | $0.55 | $19,250 | 35,000 | — | late |
| Apr 4, 2016 MForm 4 → | Apr 5, 6:01 pm EDT | Wolfgang W. ScholzVP OF ANTIBODY DISCOVERY | 101,584 | — | — | 203,166 | — | |
| Apr 4, 2016 MForm 4 → | Apr 5, 6:00 pm EDT | Robert HoffmanDirector | 11,417 | — | — | 22,833 | — | |
| Apr 4, 2016 MForm 4 → | Apr 5, 5:59 pm EDT | Thomas C VarvaroDirector | 11,417 | — | — | 22,833 | — | |
| Apr 4, 2016 MForm 4 → | Apr 5, 5:58 pm EDT | Jeffrey V. RavetchDirector | 11,417 | — | — | 22,833 | — | |
| Apr 4, 2016 MForm 4 → | Apr 5, 5:57 pm EDT | Kenneth M CohenDirector | 11,417 | — | — | 22,833 | — | |
| Apr 4, 2016 MForm 4 → | Apr 5, 5:56 pm EDT | Paul V MaierDirector | 11,417 | — | — | 22,833 | — | |
| Apr 4, 2016 MForm 4 → | Apr 5, 5:56 pm EDT | John David HansenPRESIDENT AND CEO, Director | 301,184 | — | — | 602,166 | — | |
| Apr 4, 2016 MForm 4 → | Apr 5, 5:55 pm EDT | Paul W MaffuidEXECUTIVE VICE PRESIDENT | 111,334 | — | — | 222,666 | — | |
| Apr 4, 2016 MForm 4 → | Apr 5, 5:54 pm EDT | Gregory P HansonCHIEF FINANCIAL OFFICER, SECR | 155,867 | — | — | 311,733 | — | |
| Feb 16, 2016 AForm 4 → | Feb 18, 4:42 pm EST | Wolfgang W. ScholzVP OF ANTIBODY DISCOVERY | 60,000 | $0.49 | $29,400 | 60,000 | — | |
| Feb 16, 2016 AForm 4 → | Feb 18, 4:41 pm EST | Paul W MaffuidVICE PRESIDENT | 60,000 | $0.49 | $29,400 | 60,000 | — | |
| Feb 16, 2016 AForm 4 → | Feb 18, 4:39 pm EST | Gregory P HansonCHIEF FINANCIAL OFFICER, SECR | 20,000 | $0.49 | $9,800 | 20,000 | — | |
| Feb 16, 2016 AForm 4 → | Feb 18, 4:36 pm EST | John David HansenPRESIDENT AND CEO, Director | 500,000 | $0.49 | $245,000 | 500,000 | — | |
| Aug 26, 2015 AForm 4 → | Aug 27, 3:43 pm EDT | Thomas C VarvaroDirector | 35,000 | $1.52 | $53,200 | 35,000 | — | |
| Aug 26, 2015 AForm 4 → | Aug 27, 3:41 pm EDT | Jeffrey V. RavetchDirector | 35,000 | $1.52 | $53,200 | 35,000 | — | |
| Aug 26, 2015 AForm 4 → | Aug 27, 3:40 pm EDT | Paul V MaierDirector | 35,000 | $1.52 | $53,200 | 35,000 | — | |
| Aug 26, 2015 AForm 4 → | Aug 27, 3:40 pm EDT | Robert HoffmanDirector | 35,000 | $1.52 | $53,200 | 35,000 | — | |
| Aug 26, 2015 AForm 4 → | Aug 27, 3:38 pm EDT | Kenneth M CohenDirector | 35,000 | $1.52 | $53,200 | 35,000 | — | |
| Apr 2, 2015 AForm 4 → | Apr 3, 7:52 pm EDT | Michael M WickDirector | 68,500 | $2.30 | $78,775 | 34,250 | — | |
| Apr 2, 2015 AForm 4 → | Apr 3, 7:49 pm EDT | Wolfgang W. ScholzVP of Antibody Discovery | 609,500 | $2.30 | $700,925 | 304,750 | — | |
| Apr 2, 2015 AForm 4 → | Apr 3, 7:48 pm EDT | Paul W MaffuidVice President | 668,000 | $2.30 | $768,200 | 334,000 | — | |
| Apr 2, 2015 AForm 4 → | Apr 3, 7:44 pm EDT | Jeffrey V. RavetchDirector | 68,500 | $2.30 | $78,775 | 34,250 | — | |
| Apr 2, 2015 AForm 4 → | Apr 3, 7:43 pm EDT | Paul V MaierDirector | 68,500 | $2.30 | $78,775 | 34,250 | — | |
| Apr 2, 2015 AForm 4 → | Apr 3, 7:43 pm EDT | Robert HoffmanDirector | 68,500 | $2.30 | $78,775 | 34,250 | — | |
| Apr 2, 2015 AForm 4 → | Apr 3, 7:42 pm EDT | Gregory P HansonChief Financial Officer | 935,200 | $2.30 | $1,075,480 | 467,600 | — | |
| Apr 2, 2015 AForm 4 → | Apr 3, 7:40 pm EDT | John David HansenPresident and CEO, Director | 1,806,500 | $2.30 | $2,077,475 | 903,250 | — | |
| Apr 2, 2015 AForm 4 → | Apr 3, 7:39 pm EDT | Kenneth M CohenDirector | 68,500 | $2.30 | $78,775 | 34,250 | — |